Skip to content

Starting HAART at higher CD4 cell counts means treatment can be safely stopped for longer

15% of patients who fail treatment with NRTI, NNRTIs and PIs die within 3 years

Adding ddI achieves fall in viral load in HAART patients with resistance

Abacavir leads to better CD4 increase than AZT when combined with 3TC and EFV

Compulsory licensing struggles continue: Cambodia loses rights as Brazil seeks new rights

Successfully treated HIV patients should be insured just like cancer survivors, Swiss research shows

Long-term evidence for effectiveness of nevirapine in reducing mother-to-child HIV-1 transmission

CD4 cell declines: gender, method of HIV transmission and age make a difference

An extra £11 million for sexual health and HIV this year in the UK, but is it enough?